Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells

J Biol Chem. 2004 Jan 30;279(5):3543-52. doi: 10.1074/jbc.M308682200. Epub 2003 Oct 30.

Abstract

Tight junctions (TJs) are the most apical cell-cell junctions, and claudins, the recently identified TJ proteins, are critical for maintaining cell-cell adhesion in epithelial cell sheets. Based on their in vivo distribution and the results of overexpression studies, certain claudins, including claudin-1 and -4, are postulated to increase, whereas other claudins, especially claudin-2, are postulated to decrease the overall transcellular resistance. The overall ratio among claudins expressed in a cell/tissue has been hypothesized to define the complexity of TJs. Disruption of the TJs contributes to various human diseases, and a correlation between reduction of TJ function and tumor dedifferentiation has been postulated. The epidermal growth factor (EGF) receptor (EGFR) is overexpressed in a wide spectrum of epithelial cancers, and its expression correlates with a more metastatic cancer phenotype. However, normal functioning of EGFR is essential for normal epithelial cell proliferation and differentiation. The role of EGFR-dependent signaling in the development and maintenance of epithelial TJ integrity has not been studied in detail. This study demonstrates that, in polarized Madin-Darby canine kidney II cells, EGF-induced EGFR activation significantly inhibited claudin-2 expression while simultaneously inducing cellular redistribution and increased expression of claudin-1, -3, and -4. Accompanying these EGF-induced changes in claudin expression was a 3-fold increase in transepithelial resistance, a functional measure of TJs. In contrast, there were no alterations in protein expression and/or intracellular localization of other TJ-related proteins (ZO-1 and occludin) or adherens junction-associated proteins (E-cadherin and beta-catenin), suggesting that EGF regulates TJ function through selective and differential regulation of claudins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / chemistry
  • Adherens Junctions
  • Animals
  • Blotting, Northern
  • Bromodeoxyuridine / pharmacology
  • Cell Adhesion
  • Cell Differentiation
  • Cell Division
  • Cell Line
  • Claudin-1
  • Claudin-3
  • Claudin-4
  • Claudins
  • Cycloheximide / pharmacology
  • Detergents / pharmacology
  • Dogs
  • Epithelium / metabolism
  • ErbB Receptors / metabolism*
  • Gene Expression Regulation
  • Hepatocyte Growth Factor / metabolism
  • Immunoblotting
  • Kidney / metabolism*
  • Membrane Proteins / metabolism*
  • Microscopy, Fluorescence
  • Neoplasms / metabolism
  • Octoxynol / pharmacology
  • Phenotype
  • Protein Synthesis Inhibitors / pharmacology
  • Signal Transduction
  • Tight Junctions*
  • Time Factors

Substances

  • CLDN1 protein, human
  • CLDN2 protein, human
  • CLDN3 protein, human
  • CLDN4 protein, human
  • Claudin-1
  • Claudin-3
  • Claudin-4
  • Claudins
  • Detergents
  • Membrane Proteins
  • Protein Synthesis Inhibitors
  • lactacystin
  • Hepatocyte Growth Factor
  • Octoxynol
  • Cycloheximide
  • ErbB Receptors
  • Bromodeoxyuridine
  • Acetylcysteine